Technical Background for "A Precision Medicine Approach to Develop and
  Internally Validate Optimal Exercise and Weight Loss Treatments for
  Overweight and Obese Adults with Knee Osteoarthritis" by Jiang, Xiaotong et al.
Technical Background for “A Precision Medicine
Approach to Develop Optimal Exercise and Weight
Loss Treatments for Overweight and Obese Adults
with Knee Osteoarthritis”
X.Jiang1, A.E.Nelson2, R.J.Cleveland2, D.P.Beaver3, T.A.Schwartz1, L.Arbeeva2,
C.Alvarez2, L.F.Callahan2, S.Messier4, R.Loeser2, M.R.Kosorok1
1Department of Biostatistics, University of North Carolina, Chapel Hill, NC,
2Division of Rheumatology, Allergy and Immunology and the Thurston Arthritis Research
Center, University of North Carolina, Chapel Hill, NC,
3Department of Biostatistics and Data Science, Wake Forest School of Medicine,
Winston-Salem, NC,
4Department of Health and Exercise Science, Wake Forest University, Winston-Salem, NC
Abstract
This technical report provides additional statistical background for the methodology de-
veloped in the clinical analysis of knee osteoarthritis in Jiang et al. (2020). Jiang et al. (2020)
proposed a pipeline to learn optimal treatment rules with precision medicine models and
compared them with zero-order models with a Z-test. The model performance was based on
value functions, a scalar that predicts the future reward of each decision rule. The jackknife
(i.e., leave-one-out cross validation) method was applied to estimate the value function and
its variance of several outcomes in IDEA, a randomized clinical trial studying overweight
and obese participants with knee osteoarthritis. In this report, we expand the discussion and
justification with additional statistical background. We elaborate more on the background of
precision medicine, the derivation of the jackknife estimator of value function and its esti-
mated variance, the consistency property of jackknife estimator, as well as additional simu-
lation results that reflect more of the performance of jackknife estimators. We recommend
reading Jiang et al. (2020) for clinical application and interpretation of the optimal ITR of
knee osteoarthritis as well as the overall understanding of the pipeline and recommend using
this article to understand the underlying statistical derivation and methodology.
Keywords: machine learning, individualized treatment regime, decision making, jackknife
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1 Introduction
Precision medicine (a.k.a personalized medicine) is a data-driven paradigm that aims to improve
clinical outcomes by tailoring treatments to patients as individualized as possible. For example,
cancer patients usually receive the same treatment as others who have the same type and stage of
cancer, but different people could respond to the same treatment differently. Scientists now start
to understand that genetics can cause the tumors to develop and spread, providing an explanation
to individual differences in cancer treatment. With precision medicine, such information about
genetic changes in the tumor helps clinicians choose a treatment plan that works best for each in-
dividual in terms of their well-being and outcome of interest, and it also offers the opportunity to
activate other areas of research involving drug design that target tumor changes more effectively.
Although not a new concept, precision medicine has been propelled rapidly by recent advances
in biomedical sciences and technology and it is both reproducible and generalizable.
A rigorous and reproducible decision-making process requires four well-defined components:
patient information, intervention plans, decision time points, and the decision rules. Patient in-
formation is the available data that include both prognostic covariates and clinical outcomes; the
intervention plan refers to a detailed guide that informs the type/dose/duration of the treatment
tailored to individual patients; decision time points are when and how often the decisions are
made; decision rules are functions that map patient information to interventions at each decision
point (Collins et al., 2014). Precision medicine is formalized through such decision rules that
recommend treatments by leveraging patient heterogeneity and are often called individualized
treatment rules (ITRs) (Qian and Murphy, 2011). ITR is essentially a mathematical emulation of
how clinicians make treatment decisions in practice.
To provide a concrete example, we consider a study of weight and glycemic control among
Type-1 diabetic (T1D) patients, whose glucose and physical activity were monitored continuously
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with trackers and diet and insulin recorded whenever taken (Kahkoska et al., 2019). This is a
special decision-making process called dynamic treatment regime that is commonly used in the
treatment of chronic and relapsing disorders (Collins et al., 2014). Patient information for T1D
patients includes glucose level, step counts, diet, and insulin intake, as well as medical history
and lab results from regular clinical visits. The treatment plan at each time point is whether or
not each patient needs to take an action, e.g. inject insulin, work out to increase activities, or
consume food; all plans are personalized. The decision rule decides whether the individual needs
to take an action at each time point. If yes, a recommendation of what action to take will be
given. If no, nothing needs to be done. A the next time point, responses for the previous time
point are received and incorporated as part of patient information to help make the next decision.
This decision-making process is dynamic not only because there are multiple time points (in fact
an infinite amount if we think of this an ongoing process) but also the treatment regime is adapted
to individual characteristics, as opposed to a fixed, “one-size-fits-all” rule.
2 Existing Work
We consider a single time point setting with n independent and identically distributed copies of
{Xi, Ai, Yi} for i = 1, . . . , n patients. Patient covariates are Xi ∈ X ⊆ Rp, a p × 1 vector.
Treatment is a scalar Ai ∈ A, and the outcome is also a scalar Y ∈ R. Throughout this paper,
we assume that higher values of Y represent more favorable clinical outcomes unless otherwise
specified. Existing research has been studying precision medicine based on data from both i)
randomized clinical trials where treatment assignment is independent of patient covariates hence
X ⊥ A and known propensity scores P (A|X), and ii) observational studies and not-randomized
trials where X 6⊥ A and propensity scores need to be estimated by logistic or multinomial logistic
regression depending on the number of treatments. The decision rule is defined as a function d :
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X → A where a treatment assignment Ai is obtained and Ai = d(Xi) given the i-th individual’s
clinical covariates Xi. According to Qian and Murphy (2011), the single-stage decision problem
finds the optimal ITR dopt in a class of all possible decision rulesD that maximizes the “Value” or
the expected reward of a potential outcome under a decision rule when applied to future patients.
Mathematically, this is expressed as
dopt = arg max
d∈D
V (d), (1)
where
V (d) = Ed[Y ] = E
[
Y 1{A = d(X)}
P (A|X)
]
(2)
is derived by Radon-Nikodym derivatives. The optimal ITR also satisfies
dopt(x) ∈ arg max
d∈D
Q(x, a) a.s. for all x ∈ X
where Q(x, a) = E[Y |X = x, A = a] is the “Quality” of treatment a applied at patient observa-
tion x. The relationship between the value and the quality is V (d) = E[Q(X, d(X))]. The goal
of precision medicine is to estimate dopt using n triplets of observed data dˆn.
Approaches to estimating the optimal treatments can be summarized into two major types:
regression-based and classification-based. Neither of them requires pre-specified values or strong
assumptions which is one of the reasons that makes precision medicine data-driven. Regression-
based approaches (the indirect methods) posit a traditional statistical regression model of Q, the
mean outcome conditional on patient data and treatment assignment as described above (Mur-
phy (2003), Robins (2004), Moodie et al. (2009), Moodie et al. (2014), Taylor et al. (2015)).
The optimal decision rule picks, among all potential treatments D, one treatment that yields the
highest estimated mean outcome based on the model conditioning on patient data, Qˆ. For ex-
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ample, Qian and Murphy (2011) achieved this with a two-step procedure with the `1-penalized
least squares model. Zhang et al. (2012) went on an alternative path with the counterfactuals.
Consider all possible decision rules indexed by η as in dη(X) = d(X, η) and denote the potential
outcome following decision rule d as Y d. The optimal ITR in Zhang et al. (2012) was obtained
by estimating ηopt = arg maxη E[Y dη ] with augmented inverse probability weighting estima-
tor (AIPWE) (Robins et al. (1994), Rotnitzky et al. (1998)) and defining doptη = d(X, ηopt). This
doubly robust approach exploits the outcome regression model to gain estimation precision while
being protected by doubly robustness in case the regression model or propensity score model are
misspecified.
An alternative to avoid the potential misspecification of regression models is classification-
based approaches (the direct methods) where the optimal ITR is estimated by the optimal clas-
sifier that minimizes the expected weighted misclassification error. A leading example of such
approach is Zhao et al. (2012) where the proposed Outcome Weighted Learning (OWL) model
avoids regression and model assumption by converting the estimation problem to a weighted
classification problem and applying weighted support vector machine (SVM) techniques. We
used OWL and its extensions as part of the precision medicine candidate models in the clinical
analysis and simulations described in Jiang et al. (2020) and Section 4.
3 Estimating Value Function with the Jackknife Method
The value function is often used to measure the performance of an ITR so it is important to have
an accurate estimation of its bias and standard error. The basic form of a value function estimator
is
V̂ (d) =
∑n
i=1 Yi1{Ai = d(Xi)}/Pˆ (Ai|Xi)∑n
i=1 1{Ai = d(Xi)}/Pˆ (Ai|Xi)
(3)
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which can be deemed as a weighted combination of individual outcomes. Because d is unknown
and needs to be estimated, a common method uses cross validation (CV). Assume a K-fold
CV repeated M times. Let j = 1, . . . , KM denote all CV folds regardless of repetition and
i = 1, . . . , nj denote the ith observations in the j-th overall CV fold. The CV estimator of value
function is
V̂ cv(dˆn) =
∑MK
j=1
∑nj
i=1 Yji
1{Aji=dˆ(−j)n (Xji)}
Pˆ (Aji|Xji)∑MK
j=1
∑nj
i=1
1{Aji=dˆ(−j)n (Xji)}
Pˆ (Aji|Xji)
(4)
where dˆ(−j)n is the estimated decision rule leaving out the jth CV fold of a training dataset of
size n. Pˆ (Aji|Xji) is the estimated propensity score of the test fold ji (constant if treatments
are randomized). k-fold CV requires many repetitions because a one-time split could generate
random biases, and we are unable to utilize as much training data as possible because we always
leave one fold out as test set.
Given these disadvantages, we proposed to use the jackknife method , a.k.a. leave-one out
cross validation (LOOCV), to estimate the bias and standard error of value function (Jiang et al.,
2020). The jackknife is a special case of CV, where data are divided such that one subject is a
fold and n − 1 folds are trained and then tested on the remaining one fold, repeatedly until all
folds have been used as a test set once. According to Jiang et al. (2020), jackknife makes very
few assumptions about the data distribution, only basic constraints such as i.i.d. independently
and identically distributed. Compared with a k-fold CV, it uses as much data to train as possible
generating approximately unbiased prediction error and avoids repetitions. Both the jackknife
and k-fold CV were used to estimate value functions and measure model performance. For
clinical results in knee osteoarthritis, see the results section in Jiang et al. (2020) and “Stratified
Cross Validation” subsections in its supplemental material.
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3.1 The Jackknife Estimator
The jackknife value estimator proposed in Jiang et al. (2020) has the following form
V̂ jk
(
dˆn
)
=
∑n
i=1 Yi
1{Ai=d̂(−i)n (Xi)}
Pˆ (Ai|Xi)∑n
i=1
1{Ai=d̂(−i)n (Xi)}
Pˆ (Ai|Xi)
(5)
where dˆ(−i)n represents the decision rule estimated from a training set of size n minus the i-th
observation, and similar to the CV version, Pˆ (Ai|Xi) is the estimated propensity score of the test
set i (constant if treatments are randomized). Eq 5 is a special case of Eq 4 with M = 1 and
K = n. The estimated variance of the jackknife value estimator is
V̂ar
[
Vˆ jk
(
dˆn
)]
=
1
n(n− 1)
n∑
i=1
R2i (6)
where Rjki =
1
W¯n
Ui − U¯nW¯ 2nWi is the bias-corrected form of value function inspired by the influ-
ence function, with Ui =
Yi1{Ai=dˆ(−i)n (Xi)}
P (Ai|Xi) ,Wi =
1{Ai=dˆ(−i)n (Xi)}
P (Ai|Xi) , U¯n = n
−1∑n
i=1 Ui and W¯n =
n−1
∑n
i=1Wi. Since it was omitted in Jiang et al. (2020), the derivation of the influence function-
inspired value function Rjki is provided here. Assume Y = Op(1) and E[W ] ∈ (, 1 − ) for
0 <  < 0.5.
Vˆ (d)− V0(d) =
∑n
i=1 Ui∑n
i=1 Wi
− E[U ]
E[W ]
=
n−1
∑n
i=1(Ui − E[U ])
n−1
∑n
i=1Wi
− n
−1E[U ] ·∑ni=1 (Wi − E[W ])
(n−1
∑n
i=1Wi)E[W ]
=
n−1
∑n
i=1(Ui − E[U ])
E[W ] + oP (1)
− n
−1E[U ] ·∑ni=1(Wi − E[W ])
E[W ](E[W ] + oP (1))
=
n−1
∑n
i=1(Ui − E[U ])
E[W ]
− n
−1E[U ] ·∑ni=1(Wi − E[W ])
(E[W ])2
+ oP (1)
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According to (ii) of Theorem 18.7 in Kosorok (2008)
√
n(Vˆ (d)− V0(d)) =
√
n
n∑
i=1
ψˇi + op(1)
for a fixed d, the influence function and its estimator would then be
ψˇi =
(Ui − E[U ])
E[W ]
− E[U ](Wi − E[W ])
(E[W ])2
=
1
E[W ]
Ui − E[U ]
(E[W ])2
Wi
ψ¨i =
1
W¯
Ui − U¯
W¯ 2
Wi
where Rjki follows a similar form as ψˇi. By this definition,
∑n
i=1 R
jk
i = 0, which is why R
jk
i is
bias-corrected. Typically, standard deviations are scaled with 1
n−1 to account for the n−1 degrees
of freedom in the summation. Our Eq (6) is scaled by 1
n(n−1) , because we also want to adjust for
correlation among the n training sets as the jackknife training sets all differ by one subject. The
standard error of the value estimator is ŜE =
√
V̂ar(Vˆ ).
3.2 Consistency of the Jackknife Estimator
We study two main asymptotic properties of the jackknife estimator: consistency and asymptotic
normality. Asymptotic normality is discussed in the “Simulations” section of Jiang et al. (2020), a
summarised, updated version of which is presented in Section 4. In this section, we provide proof
to the argument that “for our case the jackknife estimates of value functions are asymptotically
unbiased and their variances converge to zero as sample size increases” (Jiang et al., 2020).
First, two assumptions need to be made.
Assumption 3.1.
E[PX(dˆn(X) 6= dˆn−1(X))]→ 0
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Assumption 3.2.
E
[
Y 2
P (A|X) +
1
P (A|X)
]
<∞
Assumption 3.1 indicates that the decision rules based on training size n and training size
n − 1 are asymptotically equal in probability. This is easily satisfied when sample size goes to
infinity. Assumption 3.2 requires that the expectation of the second moment of the outcome,
adjusted by the propensity score, be finite. This is easily satisfied as response variables usually
live in a finite range in a finite dataset.
Theorem 3.1. Given Assumptions 3.1 and 3.2,
∑n
i=1
Yi1{Ai=dˆ(−i)n (Xi)}
P (Ai|Xi)∑n
i=1
1{Ai=dˆ(−i)n (Xi)}
P (Ai|Xi)
− E[Y |A = dˆn(X)]→
p
0
Proof. LetUi =
Yi1{Ai=dˆ(−i)n (Xi)}
P (Ai|Xi) ,Wi =
1{Ai=dˆ(−i)n (Xi)}
P (Ai|Xi) , Un = n
−1∑n
i=1 Ui, andWn = n
−1∑n
i=1Wi.
First,
µn = E[Un] = n−1
n∑
i=1
E
[
Yi1{Ai = dˆ(−i)n (Xi)}
P (Ai|Xi)
]
= E
[
Y 1{A = dˆn−1(X)}
P (A|X)
]
Denote µ˜n = E
[
Y 1{A=dˆn(X)}
P (A|X)
]
, then
µn − µ˜n = E
[
Y
P (A|X)
(
1{A = dˆn−1(X)} − 1{A = dˆn(X)}
)]
≤ ME
[
1{A = dˆn−1(X)} − 1{A = dˆn(X)}
]
+ E
[ |Y |
P (A|X)1
{ |Y |
P (A|X) > M
}]
→ 0
where the convergence is based on Assumption 3.1 for the first term and Assumption 3.2, which
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implies finite first moment, for the second term. Given the first term in Assumption 3.2, we have
the following property of the variance
Var[Un] = n−1Var
[
n∑
i=1
Ui
]
= n−2
n∑
i=1
n∑
j=1
[E(UiUj)− E(Ui)E(Uj)]
= n−2
n∑
i=1
n∑
j=1
[
E
(
YiYj1{Ai = dˆ(−i)n (Xi)}1{Aj = dˆ(−j)n (Xj)}
P (Ai|Xi)P (Aj|Xj)
)
− µ2n
]
→ n−2
n∑
i=1
n∑
j=1
[
E
(
YiYj1{Ai = dˆ(−i,−j)n (Xi)}1{Aj = dˆ(−i,−j)n (Xj)}
P (Ai|Xi)P (Aj|Xj)
)
− µ2n
]
= n−2
n∑
i=1
n∑
j=1

[
E
(
Y 1{A = dˆn−2(X)}
P (A|X)
)]2
− µ2n

→ n−2
n∑
i=1
n∑
j=1
(µ2n − µ2n) = 0,
where the convergences are based on Assumption 3.1. Thus, we have shown that
E[Un]− µ˜n → 0
Var[Un] → 0
Applying the same arguments as above to Wn with Assumption 3.1 and the second term in As-
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sumption 3.2,
τn = E[Wn] = E
[
1{A = dˆn−1(X)}
P (A|X)
]
τ˜n = E
[
1{A = dˆn(X)}
P (A|X)
]
= E
{
E
[
1{A = dˆn(X)}
P (A = dˆn(X)|X)
∣∣∣∣X
]}
= 1,
and similarly
E[Wn]− 1 → 0
Var[Wn] → 0
Thus by the weak law of large numbers (WLLN),
Un − µ˜n →
p
0 and Wn − 1→
p
0
which yields
Un
Wn
− µ˜n →
p
0
by the multivariate continuous mapping theorem. This completes the proof because
µ˜n = E
[
Y 1{A = dˆn(X)}
P (A|X)
]
= E[Y dˆn(X)] = E[Y |A = dˆn(X)]
by applying a version of Radon-Nikodym derivative (i.e. dP
d
dP
= 1{a = d(x)}/P (a|x) where
P denotes the distribution of (X, A, Y ) and P d denotes the distribution of (X, A, Y ) under the
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decision rule d (Qian and Murphy, 2011)) and since
∑n
i=1
Yi1{Ai=dˆ(−i)n (Xi)}
P (Ai|Xi)∑n
i=1
1{Ai=dˆ(−i)n (Xi)}
P (Ai|Xi)
− E[Y |A = dˆn(X)] = Un
Wn
− µ˜n.
4 Numerical Experiments
Various simulations have been done in the supplemental material of Jiang et al. (2020) to eval-
uate the performance of the jackknife value function estimator including asymptotic normality.
To generate simulated data triplets as introduced in Section 2, we assume a treatment of three
categories A which has a multinomial distribution with equal probability. We also assume i.i.d.
uniform distribution of three variables X1, X2, X3, the first two of which determine the decision
boundary as in E[Y ] = X1 +X2 + δ0(X1, X2, A) and the last of which serves as a nuisance vari-
able to add interference to the modeling. Four scenarios with respect to true decision boundary
δ0(X1, X2, A) were studied: concentric circles (scenario 1), nested steps (scenario 2), parallel
diagonal lines (scenario 3), and nested parabolas (scenario 4).
(1) δ0(X, A) = 1{A > 0}(1−X21 −X22 )(X21 +X22 − 3)1{A=1}
(2) δ0(X, A) = 1{A > 0}(1{X2 ≤ dX1 − 2 · 1{A = 2}e}
−1{X2 > dX1 − 2 · 1{A = 2}e})
(3) δ0(X, A) = 1{A > 0}(X1 +X2 − 1)(−X1 −X2 − 1)1{A=1}
(3) δ0(X, A) = 1{A > 0}(X2 −X21 )(X21 −X22 − 2)1{A=1}
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These four scenarios contain both linear (steps and lines) and non-linear (circles and parabolas)
relationships as well as different sizes and shapes of decision areas. Circles are the most complex
scenario because there is no lines or splines that could divide a circle, and concentric circles
make it even more difficult. Following the concentric circles, nested parabolas and steps are also
complex and the parallel lines are relatively easier boundaries. Many sample sizes are considered
50, 100, 200, 400, 800 and we repeat the simulation 100 times.
We evaluate the performance of jackknife estimators from four main aspects. First, we look
at how well the jackknife estimator performs similarly to an ideal estimator. More specifically,
we check whether the distribution of Vˆ jk (also known as Vˆ2 in the simulation results of Jiang
et al. (2020)) is identical to the distribution of the ideal empirical estimator
V emp =
∑n
i=1 Y˜i1{A˜i = dˆn(X˜i)}/P (A˜i|X˜i)∑n
i=1 1{A˜i = dˆn(X˜i)}/P (A˜i|X˜i)
(denoted as Vˆ4 in the simulation results of Jiang et al. (2020)). The entire dataset of size n is
used to train d and then tested on an independent dataset of the same distribution and size as
the training set. This is the most ideal estimator because training and test sets are completely
separate and of the same size but unattainable in reality. Simulation results (Supplemental Figure
4 in Jiang et al. (2020)) showed that the two estimators have similar distributions especially
when n is larger and decision boundaries are simpler. Using the same kernel ridge regression
(KRR) model, we increase the sample size to 800 and plot the distribution comparison of the two
estimators in Figure 1. We have compared n = 50 and n = 400 before so we are only comparing
n = 400 and n = 800 here for cleaner plots. It is easy conclude from Figure 1 that our jackknife
estimator can perform as well as the ideal estimator. With a higher sample size, the distribution
is more gathered towards the center and the distributions of all estimators are closer to Vˆ emp (the
straight purple line).
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Table 1: Coverage of the empirically true estimatorV0 with 95% CI of Vˆ jk
Sample Size 50 100 200 400 800
Scenario 1 84% 87% 92% 88% 96%
Scenario 2 91% 91% 96% 96% 92%
Scenario 3 93% 97% 96% 96% 96%
Scenario 4 89% 88% 90% 94% 93%
Second, we look at the variability of our jackknife estimator by measuring how much the
confidence interval (CI) of Vˆ jk covers the true value function V0. In Jiang et al. (2020), a 95%
CI is calculated for each simulation with the formula Vˆ jk ± z0.975 · SE(Vˆ jk) where z0.975 is
the standard normal quantile of 97.5%. We follow the same definition of coverage, which is
defined as the proportion of 100 simulations whose 95% CI contains the truth V0. Using the same
KRR model, we summarize the coverages in Table 1, adding a larger sample size n = 800 to
Supplemental Table 3 in Jiang et al. (2020). There are a few fluctuations across sample sizes for
scenarios 1 and 2 given the 5% Monte Carlo error (the maximum standard error of the coverage),
but we see a general trend where the coverage is closer to 95% as sample size grows.
Next, we check the power of the test statistic used to compare the optimal precision medicine
model (PMM) and the optimal zero-order model (ZOM). ZOMs are single, fixed treatment rules
that assign the same treatment to all subjects, which is considered simple but not necessarily
works for each subject’s situation. The model comparison is carried by a two-sample Z-test with
test statistic
T sim(dˆPMM, dˆZOM) =
V̂ (dˆPMM)− V̂ (dˆZOM)√∑n
i=1(RPMM,i−RZOM, i)2
n(n−1)
(Jiang et al., 2020). Power is the true positive rate of correctly detecting a significant effect of
PMM over ZOM and is estimated as the proportion of 100 simulations whose p-values are under
0.05. Results (Supplemental Table 4 in Jiang et al. (2020)) showed low powers when sample
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Table 2: Estimated power of jackknife T sim based on 100 simulations
Sample Size 50 100 200 400 800
Scenario 1 13% 7% 18% 38% 67%
Scenario 2 16% 13% 23% 34% 49%
Scenario 3 15% 24% 41% 81% 94%
Scenario 4 11% 15% 35% 56% 85%
size was low (n ≤ 200) but the estimated power increased by a lot from n = 200 to n = 400.
Table 2 contains the new sample size n = 800 and we see a bigger increase for all scenarios
as we increase the sample size beyond n = 400. Simpler scenarios such as lines and parabolas
have higher power than more complex scenarios such as circles and steps. There is still room to
improve power for scenarios 1 and 2.
Last, we use simulations to study the asymptotic property of the jackknife estimator. Jiang
et al. (2020) used the following shifted test statistic to measure how far apart are the PMM and
ZPM value functions.
T sim0 =
[Vˆ (dˆPMM)− Vˆ (dˆZOM)]− [V0(dˆPMM)− V0(dˆZOM)]√∑n
i=1(RPMM,i−RZOM,i)2
n(n−1)
(7)
Both the Shapiro-Wilk test (Supplemental Table 5 in Jiang et al. (2020)) and Q-Q plots of the dis-
tribution of T sim0 over 100 simulations versus standard normal distribution (Supplemental Figure
5 in Jiang et al. (2020)) are used to learn the normality of T sim0 . Table 3 extends the Shapiro-Wilk
test to sample size of n = 800. The p-values are still well above 0.05, indicating that there is not
enough evidence to reject the null hypothesis that T sim0 has a standard normal distribution for all
scenarios and sample sizes n ≤ 100. Next we look at a Q-Q plot (Figure 2) to visually check
if the distribution of T sim0 is normally distributed. Similar as before, we only show n = 400
and n = 800 here to focus on higher sample sizes because Jiang et al. (2020) compared lower
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Table 3: P-values of Shapiro-Wilk test of normality on jackknife T sim0
Sample Size 50 100 200 400 800
Scenario 1 0.20 0.37 0.15 0.18 0.74
Scenario 2 0.85 0.92 0.41 0.79 0.64
Scenario 3 <0.01 0.99 0.13 0.61 0.87
Scenario 4 <0.01 0.67 0.81 0.84 0.86
sample sizes n = 50 and n = 400. As sample size doubled to n = 800, the scatter points of
the distribution of T sim0 live more on the straight diagonal line, implying closer to normality than
n = 800 for all scenarios. Albeit there are still some outliers (especially for scenario 2), we see
improvement at the two tails for other scenarios.
5 Summary
Jiang et al. (2020) used the jackknife method to estimate value functions and found the optimal in-
dividualized treatments for participants enrolled in a knee osteoarthritis clinical trial. We expand
the discussion and justification with additional statistical background in this technical report. We
have introduced precision medicine and existing methods in greater detail (Sections 1 and 2),
provided the definition and derivation of jackknife estimators (Section 3.1), showed theoretical
evidence for the consistency of jackknife estimators (Section 3.2), and numerical evidence for
the performance and properties of jackknife estimators with a higher sample size (Section 4). We
recommend reading Jiang et al. (2020) for clinical application and interpretation of the optimal
ITR of knee osteoarthritis as well as an overall understanding of the pipeline, and recommend
reading this article for more in-depth statistical derivation and methodology.
17
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